{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:52Z","timestamp":1791295732925,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1378\/chest.11-2306","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T02:39:00Z","timestamp":1328582340000},"page":"e637S-e668S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":380,"special_numbering":"S","title":["Primary and Secondary Prevention of Cardiovascular Disease"],"prefix":"10.1016","volume":"141","author":[{"given":"Per Olav","family":"Vandvik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Michael","family":"Lincoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Gutterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Sonnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Alonso-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten G.","family":"Lansberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 suppl","key":"10.1378\/chest.11-2306_bib1","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.11-2290","article-title":"Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"MacLean","year":"2012","journal-title":"Chest"},{"issue":"2 suppl","key":"10.1378\/chest.11-2306_bib2","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1378\/chest.11-2288","article-title":"Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"issue":"16","key":"10.1378\/chest.11-2306_bib3","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1378\/chest.11-2306_bib4","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjmed.2011.01.018","article-title":"Effect of aspirin on mortality in the primary prevention of cardiovascular disease","volume":"24","author":"Raju","year":"2011","journal-title":"Am J Med"},{"issue":"9759","key":"10.1378\/chest.11-2306_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"issue":"9754","key":"10.1378\/chest.11-2306_bib6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"issue":"2 suppl","key":"10.1378\/chest.11-2306_bib7","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"issue":"18","key":"10.1378\/chest.11-2306_bib8","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"9678","key":"10.1378\/chest.11-2306_bib9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1378\/chest.11-2306_bib10","doi-asserted-by":"crossref","first-page":"b2584","DOI":"10.1136\/bmj.b2584","article-title":"An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study","volume":"339","author":"Collins","year":"2009","journal-title":"BMJ"},{"key":"10.1378\/chest.11-2306_bib11","doi-asserted-by":"crossref","first-page":"a3083","DOI":"10.1136\/bmj.a3083","article-title":"Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study","volume":"338","author":"de Ruijter","year":"2009","journal-title":"BMJ"},{"issue":"6618","key":"10.1378\/chest.11-2306_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"Randomised trial of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1378\/chest.11-2306_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group","volume":"321","author":"Steering Committee of the Physicians' Health Study Research Group","year":"1989","journal-title":"N Engl J Med"},{"issue":"9098","key":"10.1378\/chest.11-2306_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","volume":"351","year":"1998","journal-title":"Lancet"},{"issue":"9118","key":"10.1378\/chest.11-2306_bib15","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"9250","key":"10.1378\/chest.11-2306_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(00)03539-X","article-title":"Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice","volume":"357","author":"de Gaetano","year":"2001","journal-title":"Lancet"},{"issue":"13","key":"10.1378\/chest.11-2306_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1378\/chest.11-2306_bib18","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/hrt.2008.150698","article-title":"Age threshold for vascular prophylaxis by aspirin in patients without diabetes","volume":"94","author":"Bulugahapitiya","year":"2008","journal-title":"Heart"},{"issue":"1","key":"10.1378\/chest.11-2306_bib19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/dc07-9917","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"30","author":"Buse","year":"2007","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1378\/chest.11-2306_bib20","first-page":"S72","article-title":"Aspirin therapy in diabetes","volume":"27","author":"Colwell","year":"2004","journal-title":"Diabetes Care"},{"issue":"7505","key":"10.1378\/chest.11-2306_bib21","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/bmj.330.7505.1440","article-title":"Aspirin for everyone older than 50? For","volume":"330","author":"Elwood","year":"2005","journal-title":"BMJ"},{"issue":"1","key":"10.1378\/chest.11-2306_bib22","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary","volume":"28","author":"Ryd\u00e9n","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.11-2306_bib23","doi-asserted-by":"crossref","first-page":"b4531","DOI":"10.1136\/bmj.b4531","article-title":"Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials","volume":"339","author":"De Berardis","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1378\/chest.11-2306_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diabres.2009.09.029","article-title":"Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1378\/chest.11-2306_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.amjcard.2004.05.026","article-title":"Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention","volume":"94","author":"Saw","year":"2004","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1378\/chest.11-2306_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"10.1378\/chest.11-2306_bib27","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.amjcard.2009.02.021","article-title":"Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients","volume":"103","author":"Patel","year":"2009","journal-title":"Am J Cardiol"},{"issue":"2 suppl","key":"10.1378\/chest.11-2306_bib28","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"issue":"9038","key":"10.1378\/chest.11-2306_bib29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"7329","key":"10.1378\/chest.11-2306_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"issue":"4","key":"10.1378\/chest.11-2306_bib31","first-page":"CD001246","article-title":"Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients","author":"Sudlow","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1378\/chest.11-2306_bib32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjmed.2004.01.014","article-title":"Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis","volume":"116","author":"Schleinitz","year":"2004","journal-title":"Am J Med"},{"issue":"3","key":"10.1378\/chest.11-2306_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2005.06.026","article-title":"A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK","volume":"109","author":"Karnon","year":"2006","journal-title":"Int J Cardiol"},{"issue":"suppl 4","key":"10.1378\/chest.11-2306_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00019053-200422004-00005","article-title":"The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study","volume":"22","author":"Durand-Zaleski","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"18","key":"10.1378\/chest.11-2306_bib35","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1001\/archinte.160.18.2773","article-title":"Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack","volume":"160","author":"Sarasin","year":"2000","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1378\/chest.11-2306_bib36","first-page":"CD005158","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease","author":"Keller","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.11-2306_bib37","doi-asserted-by":"crossref","first-page":"c117","DOI":"10.1136\/bmj.c117","article-title":"Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses","volume":"340","author":"Sun","year":"2010","journal-title":"BMJ"},{"issue":"9431","key":"10.1378\/chest.11-2306_bib38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"9075","key":"10.1378\/chest.11-2306_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)01180-X","article-title":"Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS)","volume":"350","author":"Coumadin Aspirin Reinfarction Study (CARS) Investigators","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1378\/chest.11-2306_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","author":"The Post Coronary Artery Bypass Graft Trial Investigators","year":"1997","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1378\/chest.11-2306_bib41","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.CIR.98.11.1064","article-title":"Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: organization to assess strategies for ischemic syndromes (OASIS) pilot study results","volume":"98","author":"Anand","year":"1998","journal-title":"Circulation"},{"issue":"13","key":"10.1378\/chest.11-2306_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"issue":"9327","key":"10.1378\/chest.11-2306_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"van Es","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1378\/chest.11-2306_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-143-4-200508160-00005","article-title":"Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit","volume":"143","author":"Rothberg","year":"2005","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1378\/chest.11-2306_bib45","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","article-title":"Aspirin dose for the prevention of cardiovascular disease: a systematic review","volume":"297","author":"Campbell","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"10.1378\/chest.11-2306_bib46","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2005.01.049","article-title":"Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials","volume":"95","author":"Serebruany","year":"2005","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1378\/chest.11-2306_bib47","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"issue":"9711","key":"10.1378\/chest.11-2306_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1378\/chest.11-2306_bib49","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.hjr.0000152239.28456.36","article-title":"The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study","volume":"11","author":"Lamy","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"40","key":"10.1378\/chest.11-2306_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta8400","article-title":"Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation","volume":"8","author":"Main","year":"2004","journal-title":"Health Technol Assess"},{"issue":"5","key":"10.1378\/chest.11-2306_bib51","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1365-2796.2004.01324.x","article-title":"Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial","volume":"255","author":"Lindgren","year":"2004","journal-title":"J Intern Med"},{"issue":"6","key":"10.1378\/chest.11-2306_bib52","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jacc.2004.11.051","article-title":"Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation","volume":"45","author":"Weintraub","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1378\/chest.11-2306_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-142-4-200502150-00007","article-title":"A cost-effectiveness analysis of combination antiplatelet therapy for high-risk acute coronary syndromes: clopidogrel plus aspirin versus aspirin alone","volume":"142","author":"Schleinitz","year":"2005","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1378\/chest.11-2306_bib54","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1378\/chest.11-2306_bib55","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.jacc.2007.07.058","article-title":"Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes","volume":"50","author":"Storey","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1378\/chest.11-2306_bib56","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1378\/chest.11-2306_bib57","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1378\/chest.11-2306_bib58","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMp0907122","article-title":"Weighing benefits and risks\u2014the FDA's review of prasugrel","volume":"361","author":"Unger","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1378\/chest.11-2306_bib59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198108063050601","article-title":"Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography","volume":"305","author":"Asinger","year":"1981","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1378\/chest.11-2306_bib60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-100-6-789","article-title":"Left ventricular mural thrombi complicating acute myocardial infarction. Long-term follow-up with serial echocardiography","volume":"100","author":"Weinreich","year":"1984","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1378\/chest.11-2306_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9149(88)91360-4","article-title":"Left ventricular thrombus formation after first anterior wall acute myocardial infarction","volume":"62","author":"Lamas","year":"1988","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1378\/chest.11-2306_bib62","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0735-1097(90)90275-T","article-title":"Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction","volume":"15","author":"Keren","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1378\/chest.11-2306_bib63","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ahj.2009.03.020","article-title":"Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era","volume":"157","author":"Osherov","year":"2009","journal-title":"Am Heart J"},{"issue":"9","key":"10.1378\/chest.11-2306_bib64","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.amjcard.2010.06.043","article-title":"Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy","volume":"106","author":"Solheim","year":"2010","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1378\/chest.11-2306_bib65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11239-010-0448-6","article-title":"Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial","volume":"30","author":"Schwalm","year":"2010","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10.1378\/chest.11-2306_bib66","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0735-1097(93)90409-T","article-title":"Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis","volume":"22","author":"Vaitkus","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1378\/chest.11-2306_bib67","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/STROKEAHA.107.500199","article-title":"Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)","volume":"39","author":"Healey","year":"2008","journal-title":"Stroke"},{"issue":"4","key":"10.1378\/chest.11-2306_bib68","first-page":"CD002133","article-title":"Ticlopidine versus oral anticoagulation for coronary stenting","author":"Cosmi","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1378\/chest.11-2306_bib69","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4244\/V5I3A60","article-title":"Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials","volume":"5","author":"Tamhane","year":"2009","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1378\/chest.11-2306_bib70","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1378\/chest.11-2306_bib71","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1378\/chest.11-2306_bib72","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1161\/CIRCULATIONAHA.108.842757","article-title":"Early stent thrombosis: past, present, and future","volume":"119","author":"Cook","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1378\/chest.11-2306_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-8703(94)90004-3","article-title":"Thrombosis and restenosis after stenting in failed angioplasty: comparison with elective stenting","volume":"128","author":"Foley","year":"1994","journal-title":"Am Heart J"},{"issue":"3","key":"10.1378\/chest.11-2306_bib74","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.85.3.916","article-title":"Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty","volume":"85","author":"Roubin","year":"1992","journal-title":"Circulation"},{"issue":"1","key":"10.1378\/chest.11-2306_bib75","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJM199101033240103","article-title":"Angiographic follow-up after placement of a self-expanding coronary-artery stent","volume":"324","author":"Serruys","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.11-2306_bib76","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jacc.2010.08.631","volume":"57","author":"Suh","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1378\/chest.11-2306_bib77","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ahj.2007.12.024","article-title":"Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention","volume":"155","author":"Biondi-Zoccai","year":"2008","journal-title":"Am Heart J"},{"issue":"9748","key":"10.1378\/chest.11-2306_bib78","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1378\/chest.11-2306_bib79","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2007.10.002","article-title":"2007 focused update of the ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice guidelines","volume":"51","author":"King","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1378\/chest.11-2306_bib80","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurheartj\/ehi138","article-title":"Guidelines for percutaneous coronary interventions","volume":"26","author":"Silber","year":"2005","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1378\/chest.11-2306_bib81","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/eurheartj\/ehn417","article-title":"Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study","volume":"30","author":"Jolly","year":"2009","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1378\/chest.11-2306_bib82","first-page":"182","article-title":"Long-term peripheral stent evaluation using angioscopy","volume":"10","author":"Bergeron","year":"1991","journal-title":"Int Angiol"},{"issue":"2","key":"10.1378\/chest.11-2306_bib83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0735-1097(94)90417-0","article-title":"Neointimal coverage of stents in human coronary arteries observed by angioscopy","volume":"23","author":"Ueda","year":"1994","journal-title":"J Am Coll Cardiol"},{"issue":"9591","key":"10.1378\/chest.11-2306_bib84","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"issue":"14","key":"10.1378\/chest.11-2306_bib85","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","article-title":"A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease","volume":"50","author":"Sch\u00f6mig","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1378\/chest.11-2306_bib86","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"issue":"24","key":"10.1378\/chest.11-2306_bib87","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"issue":"16","key":"10.1378\/chest.11-2306_bib88","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1161\/01.CIR.0000127105.99982.21","article-title":"Stent thrombosis after successful sirolimus-eluting stent implantation","volume":"109","author":"Jeremias","year":"2004","journal-title":"Circulation"},{"issue":"9281","key":"10.1378\/chest.11-2306_bib89","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1378\/chest.11-2306_bib90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00380-003-0704-1","article-title":"A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation","volume":"18","author":"Pekdemir","year":"2003","journal-title":"Heart Vessels"},{"issue":"19","key":"10.1378\/chest.11-2306_bib91","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1378\/chest.11-2306_bib92","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.amjcard.2006.08.034","article-title":"Long-term versus short-term clopidogrel therapy in patients undergoing coronary stenting (from the Randomized Argentine Clopidogrel Stent [RACS] trial)","volume":"99","author":"Bernardi","year":"2007","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1378\/chest.11-2306_bib93","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00019501-200409000-00008","article-title":"The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention","volume":"15","author":"Akbulut","year":"2004","journal-title":"Coron Artery Dis"},{"issue":"12","key":"10.1378\/chest.11-2306_bib94","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1378\/chest.11-2306_bib95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.297.2.joc60179","article-title":"Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation","volume":"297","author":"Eisenstein","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1378\/chest.11-2306_bib96","first-page":"CD003333","article-title":"Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm","author":"Lip","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1378\/chest.11-2306_bib97","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"148","author":"Cleland","year":"2004","journal-title":"Am Heart J"},{"issue":"12","key":"10.1378\/chest.11-2306_bib98","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.11-2306_bib99","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","article-title":"Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study","volume":"8","author":"Cokkinos","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1378\/chest.11-2306_bib100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0002-8703(97)70103-0","article-title":"Effects of warfarin on markers of hypercoagulability in patients with heart failure","volume":"134","author":"Jafri","year":"1997","journal-title":"Am Heart J"},{"key":"10.1378\/chest.11-2306_bib101","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary artery disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212601342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212601342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:34:29Z","timestamp":1757918069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212601342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0012369212601342"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-2306","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary and Secondary Prevention of Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-2306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}